GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 19.40
+0.39 (2.05%)
At close: Apr 21, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 7.95 billion as of April 21, 2026. Its market cap has increased by 36.36% in one year.
Market Cap
7.95B
Enterprise Value
7.08B
Revenue
793.25M
Ranking
n/a
PE Ratio
55.43
Stock Price
19.40
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 7.95B, an increase of 4.86%. That is a compound annual growth rate of 1.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 7.79B | 23.76% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Ausun Pharmaceutical | 8.34B |
| Daan Gene | 8.29B |
| Jiangsu Aidea Pharmaceutical Group | 8.15B |
| Acrobiosystems | 8.05B |
| Chengdu Kanghua Biological Products | 7.77B |
| Suzhou Fengbei Biotech Stock | 7.75B |
| Nanjing Vazyme Biotech | 7.50B |
| Shanghai OPM Biosciences | 7.26B |